Adiponectin As an Anti-inflammatory Factor

Overview

Journal Clin Chim Acta

Specialty Biochemistry

Date 2007 Mar 9

PMID 17343838

Citations 327

Authors

Noriyuki Ouchi

Kenneth Walsh

Affiliations

Soon will be listed here.

Abstract

Obesity is characterized by low-grade systemic inflammation. Adiponectin is an adipose tissue-derived hormone, which is downregulated in obesity. Adiponectin displays protective actions on the development of various obesity-linked diseases. Several clinical studies demonstrate the inverse relationship between plasma adiponectin levels and several inflammatory markers including C-reactive protein. Adiponectin attenuates inflammatory responses to multiple stimuli by modulating signaling pathways in a variety of cell types. The anti-inflammatory properties of adiponectin may be a major component of its beneficial effects on cardiovascular and metabolic disorders including atherosclerosis and insulin resistance. In this review, we focus on the role of adiponectin in regulation of inflammatory response and discuss its potential as an anti-inflammatory marker.

Citing Articles

Recent development of mitochondrial metabolism and dysfunction in osteoarthritis.

Guo P, Alhaskawi A, Adel Abdo Moqbel S, Pan Z Front Pharmacol. 2025; 16:1538662.

PMID: 40017603 PMC: 11865096. DOI: 10.3389/fphar.2025.1538662.

A comprehensive review of medicinal plants and their beneficial roles in alleviating bisphenol A-induced organ toxicity.

Dolatabadi S, Oskuei S, Mehri S, Hosseinzadeh H Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39932506 DOI: 10.1007/s00210-025-03795-8.

The Importance of Edible Medicinal Mushrooms and Their Potential Use as Therapeutic Agents Against Insulin Resistance.

Nemeth Z, Paulinne Bukovics M, Sumegi L, Sturm G, Takacs I, Simon-Szabo L Int J Mol Sci. 2025; 26(2).

PMID: 39859540 PMC: 11765957. DOI: 10.3390/ijms26020827.

AdipoRon's Impact on Alzheimer's Disease-A Systematic Review and Meta-Analysis.

Barbalho S, Fornari Laurindo L, de Oliveira Zanuso B, da Silva R, Gallerani Caglioni L, Nunes Junqueira de Moraes V Int J Mol Sci. 2025; 26(2).

PMID: 39859201 PMC: 11765103. DOI: 10.3390/ijms26020484.

Sex-Specific Differences in the Pathophysiology of Hypertension.

Zhang H, Singal P, Ravandi A, Rabinovich-Nikitin I Biomolecules. 2025; 15(1).

PMID: 39858537 PMC: 11763887. DOI: 10.3390/biom15010143.

References

Matsushita K, Yatsuya H, Tamakoshi K, Wada K, Otsuka R, Zhang H . Inverse association between adiponectin and C-reactive protein in substantially healthy Japanese men. Atherosclerosis. 2005; 188(1):184-9. DOI: 10.1016/j.atherosclerosis.2005.10.031. View

Sattar N, Wannamethee G, Sarwar N, Tchernova J, Cherry L, Michael Wallace A . Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation. 2006; 114(7):623-9. DOI: 10.1161/CIRCULATIONAHA.106.618918. View

Choi K, Ryu O, Lee K, Kim H, Seo J, Kim S . Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome. Diabetes Res Clin Pract. 2006; 75(2):235-40. DOI: 10.1016/j.diabres.2006.06.019. View

Wittchen F, Suckau L, Witt H, Skurk C, Lassner D, Fechner H . Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets. J Mol Med (Berl). 2006; 85(3):257-71. PMC: 1820750. DOI: 10.1007/s00109-006-0122-9. View

Fujioka D, Kawabata K, Saito Y, Kobayashi T, Nakamura T, Kodama Y . Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart. Am J Physiol Heart Circ Physiol. 2006; 290(6):H2409-16. DOI: 10.1152/ajpheart.00987.2005. View

Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y . Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999; 100(25):2473-6. DOI: 10.1161/01.cir.100.25.2473. View

Hohlfeld T, Meyer-Kirchrath J, Vogel Y, Schror K . Reduction of infarct size by selective stimulation of prostaglandin EP(3)receptors in the reperfused ischemic pig heart. J Mol Cell Cardiol. 2000; 32(2):285-96. DOI: 10.1006/jmcc.1999.1072. View

Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y . Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000; 20(6):1595-9. DOI: 10.1161/01.atv.20.6.1595. View

Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N . Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood. 2000; 96(5):1723-32. View

10.

Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H . Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation. 2000; 102(11):1296-301. DOI: 10.1161/01.cir.102.11.1296. View

11.

Lusis A . Atherosclerosis. Nature. 2000; 407(6801):233-41. PMC: 2826222. DOI: 10.1038/35025203. View

12.

Waltenberger J . Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res. 2001; 49(3):554-60. DOI: 10.1016/s0008-6363(00)00228-5. View

13.

Katsuki A, Sumida Y, Murata K, Furuta M, Tsuchihashi K, Hori Y . Troglitazone reduces plasma levels of tumour necrosis factor-alpha in obese patients with type 2 diabetes. Diabetes Obes Metab. 2001; 2(3):189-91. DOI: 10.1046/j.1463-1326.2000.00072.x. View

14.

Fruebis J, Tsao T, Javorschi S, Erickson M, Yen F, Bihain B . Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A. 2001; 98(4):2005-10. PMC: 29372. DOI: 10.1073/pnas.98.4.2005. View

15.

Combs T, Wagner J, Berger J, Doebber T, Wang W, Zhang B . Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology. 2002; 143(3):998-1007. DOI: 10.1210/endo.143.3.8662. View

16.

Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H . Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 2002; 8(7):731-7. DOI: 10.1038/nm724. View

17.

Lindsay R, Funahashi T, Hanson R, Matsuzawa Y, Tanaka S, Tataranni P . Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet. 2002; 360(9326):57-8. DOI: 10.1016/S0140-6736(02)09335-2. View

18.

Xiao C, Yuhki K, Hara A, Fujino T, Kuriyama S, Yamada T . Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4. Circulation. 2004; 109(20):2462-8. DOI: 10.1161/01.CIR.0000128046.54681.97. View

19.

Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K . Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension. 2004; 43(6):1318-23. DOI: 10.1161/01.HYP.0000129281.03801.4b. View

20.

Choi K, Lee J, Lee K, Seo J, Oh J, Kim S . Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans. Clin Endocrinol (Oxf). 2004; 61(1):75-80. DOI: 10.1111/j.1365-2265.2004.02063.x. View